Search Within

James W Young

Formats
  1. Meeting Abstract (183)
  2. Journal Article (124)
  3. Research Letter (5)
  4. Conference Paper (3)
  5. Book Section (2)
  6. Editorial (2)
Groups
  1. Bone Marrow Transplant (319)
  2. Center for Hematologic Malignancies (319)
  3. Department of Medicine (319)
  4. Hematologic Malignancies, Division of (319)
  5. Sloan Kettering Institute Faculty (191)
  6. GSK Faculty (190)

More Groups

People
  1. Esperanza Papadopoulos (188)
  2. Hugo Castro-Malaspina (157)
  3. Ann Jakubowski (155)
  4. Miguel-Angel Perales (145)
  5. Richard O'Reilly (145)
  6. Sergio Giralt (119)

More People

Years
  1. 2025 (2)
  2. 2023 (5)
  3. 2022 (8)
  4. 2021 (7)
  5. 2020 (16)
  6. 2019 (5)

More Years

Publications
  1. Blood (125)
  2. Biology of Blood and Marrow Transplantation (81)
  3. Bone Marrow Transplantation (14)
  4. Journal of Immunology (8)
  5. Blood Advances (7)
  6. Leukemia and Lymphoma (6)

More Publications

Publishers
  1. American Society of Hematology (132)
  2. Elsevier Inc. (89)
  3. Nature Publishing Group (17)
  4. American Association for Cancer Research (9)
  5. The American Association of Immunologists, Inc (8)
  6. Elsevier Science, Inc. (7)

More Publishers

Results (319)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T-cell depleted (TCD) stem cell transplants (SCT) from HLA identical siblings
    Meeting Abstract

    Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K. C.; Chiu, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells
    Journal Article

    Münz, C.; Dao, T.; Ferlazzo, G.; De Cos, M. A.; Goodman, K.; Young, J. W.
    Blood (2005)

    Fulltext@MSK | Save
  • Dendritic cells have the option to express IDO-mediated suppression or not
    Journal Article

    Munn, D. H.; Mellor, A. L.; Rossi, M.; Young, J. W.
    Blood (2005)

    Fulltext@MSK | Save
  • Human dendritic cells: Potent antigen-presenting cells at the crossroads of innate and adaptive immunity
    Journal Article

    Rossi, M.; Young, J. W.
    Journal of Immunology (2005)

    Fulltext@MSK | Save
  • Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
    Journal Article

    Boruchov, A. M.; Heller, G.; Veri, M. C.; Bonvini, E.; Ravetch, J. V.; Young, J. W.
    Journal of Clinical Investigation (2005)

    Fulltext@MSK | Save
  • Frequency of molecular and PET/CT complete remissions in patients with multiple myeloma after autologous followed by reduced-intensity allogeneic stem cell transplants
    Meeting Abstract

    Zhou, P.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Miller, K.; Pandit-Taskar, N.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
    Blood (2004)

    Fulltext@MSK | Save
  • Langerhans cells modified by gene transfer of full length CMV pp65 are more potent inducers of cytolytic T lymphocytes in a CD4-dependent manner than either CMV p495 gene-modified or p495 peptide-pulsed Langerhans cells
    Meeting Abstract

    Yuan, J.; Latouche, J. B.; Hodges, J.; Heller, G.; Riviere, I.; Sadelain, M.; Young, J. W.
    Molecular Therapy (2004)

    Fulltext@MSK | Save
  • Vaccine reponses following unmodified or T cell depleted unrelated and mismatched related HCT
    Meeting Abstract

    Small, T. N.; Papadopoulos, E. B.; Boulad, F.; Kernan, N. A.; Ford, R.; Taylor, J.; Casson, A.; Torok-Castanza, J.; Cuello, B.; Young, J. W.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation
    Meeting Abstract

    Castro-Malaspina, H.; Papadopoulos, E.; Jakubowski, A.; Perales, M. A.; Young, J.; Hsu, K.; Boulad, F.; Prasad, V.; Small, T.; Kernan, N.; more...
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Castro-Malaspina, H.; Hsu, K. C.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Blood (2004)

    Fulltext@MSK | Save